Clinical Trial Update: Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric Junction [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for preoperative concurrent chemoradiotherapy in potentially resectable gastroesophageal junction adenocarcinoma completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Adenocarcinoma

Snippet

Sponsor: Hebei Medical University | Conditions: Gastroesophageal Junction Adenocarcinoma | Phase 2, Phase 3 | Status: COMPLETED